Join us at the Oppenheimer 32nd Annual Virtual Healthcare Conference!
Tarsier pharma will be participating at the Oppenheimer 32nd Annual Healthcare Conference taking place virtually on March 15-17, 2022. The event will provide investors a broad spectrum of public and private healthcare companies, spanning all major sectors of the healthcare industry. Dr. Daphne Haim-Langford, Founder and CEO of Tarsier, will present a corporate update and hold 1X1 meetings with stakeholders. Investors interested in participating or meeting with Tarsier may contact their Oppenheimer’s representative.
More information about the event can be found here.